The IκB kinase complex and NF-κB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1

被引:125
|
作者
Krappmann, D
Wegener, E
Sunami, Y
Esen, M
Thiel, A
Mordmuller, B
Scheidereit, C
机构
[1] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
[2] Deutsch Rheuma Forsch Zentrum Berlin, D-10117 Berlin, Germany
关键词
D O I
10.1128/MCB.24.14.6488-6500.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) recognize conserved products of microbial pathogens to initiate the innate immune response. TLR4 signaling is triggered upon binding of lipopolysaccharides (LPS) from gram-negative bacteria. Using comparative gene expression profiling, we demonstrate a master regulatory role of IkappaB kinase (IKK)/NF-kappaB signaling for immediate-early gene induction after LPS engagement in precursor B cells. IKK/NF-kappaB signaling controls a large panel of gene products associated with signaling and transcriptional activation and repression. Intriguingly, the induction of AP-1 activity by LPS in precursor B cells and primary dendritic cells fully depends on the IKK/NF-kappaB pathway, which promotes expression of several AP-1 family members, including JunB, JunD, and B-ATF. In pre-B cells, AP-1 augments induction of a subset of primary NF-kappaB targets, as shown for chemokine receptor 7 (CCR7) and immunoglobulin kappa light chain. Thus, our data illustrate that NF-kappaB orchestrates immediate-early effects of LPS signaling and controls secondary AP-1 activation to mount an appropriate biological response.
引用
收藏
页码:6488 / 6500
页数:13
相关论文
共 50 条
  • [1] NF-κB and AP-1 gene expression inhibitors
    不详
    DRUG DISCOVERY TODAY, 2001, 6 (08) : 437 - 437
  • [2] Small molecule regulators of AP-1 and NF-κB
    Manning, AN
    INFLAMMATORY PROCESSES: MOLECULAR MECHANISMS AND THERAPEUTIC OPP ORTUNITIES, 2000, : 39 - 51
  • [3] Elafin prevents lipopolysaccharide-induced AP-1 and NF-κB activation via an effect on the ubiquitin-proteasome pathway
    Butler, Marcus W.
    Robertson, Ian
    Greene, Catherine M.
    O'Neill, Shane J.
    Taggart, Clifford C.
    McElvaney, Noel G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (46) : 34730 - 34735
  • [4] Lipopolysaccharide-induced NF-κB activation in human endothelial cells involves degradation of IκBα but not IκBβ1
    Zen, K
    Karsan, A
    Eunson, T
    Yee, E
    Harlan, JM
    EXPERIMENTAL CELL RESEARCH, 1998, 243 (02) : 425 - 433
  • [5] Glabridin inhibits lipopolysaccharide-induced activation of a microglial cell line, BV-2, by blocking NF-κB and AP-1
    Lee, Ki Hoon
    Park, Sun Hong
    Kang, Jong Soon
    Han, Sang-Bae
    Lee, Kiho
    Park, Song-Kyu
    Kim, Hwan Mook
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [6] Glabridin inhibits Lipopolysaccharide-induced Activation of a Microglial Cell Line, BV-2, by Blocking NF-κB and AP-1
    Park, Sun Hong
    Kang, Jong Soon
    Yoon, Yeo Dae
    Lee, Kiho
    Kim, Kang-Jeon
    Lee, Ki Hoon
    Lee, Chang Woo
    Moon, Eun-Yi
    Han, Sang-Bae
    Kim, Bong Hee
    Kim, Hwan Mook
    Park, Song-Kyu
    PHYTOTHERAPY RESEARCH, 2010, 24 : S29 - S34
  • [7] Achieving stability of lipopolysaccharide-induced NF-κB activation
    Covert, MW
    Leung, TH
    Gaston, JE
    Baltimore, D
    SCIENCE, 2005, 309 (5742) : 1854 - 1857
  • [8] Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor κB (NF-κB) Activation in Macrophages
    Liu, Zhaoyu
    Zhang, Wencheng
    Zhang, Miao
    Zhu, Huaiping
    Moriasi, Cate
    Zou, Ming-Hui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (04) : 2312 - 2320
  • [9] Oxidative stress and gene expression:: The AP-1 and NF-κB connections
    Karin, M
    Takahashi, T
    Kapahi, P
    Delhase, M
    Chen, Y
    Makris, C
    Rothwarf, D
    Baud, V
    Natoli, G
    Guido, F
    Li, NX
    BIOFACTORS, 2001, 15 (2-4) : 87 - 89
  • [10] Activation of transcription factors AP-1 and Rel/NF-κB and regulation of gene expression by acetaldehyde
    Román, J
    Parés, A
    Gassó, M
    Giménez, A
    Rubio, M
    Caballería, J
    Rodés, J
    Fernández-Checa, JC
    HEPATOLOGY, 1998, 28 (04) : 237A - 237A